Research Shows Zeaxanthin Enhances Immune Response Against Cancer
Recent findings suggest that zeaxanthin, a nutrient commonly associated with eye health, may also play a role in enhancing the body’s defenses against cancer.
At the University of Chicago, scientists have discovered that zeaxanthin, a plant-derived carotenoid, could improve immune response by boosting the ability of certain immune cells to combat tumors. The study, published in Cell Reports Medicine, suggests zeaxanthin’s potential as an easy-to-obtain supplement that could enhance the efficacy of existing cancer immunotherapies.
“It was unexpected to find that zeaxanthin, which we know for its benefits to eye health, has this novel function in promoting anti-tumor immunity,” stated Jing Chen, PhD, a senior author of the study. “Our research indicates that this straightforward dietary nutrient has the potential to strengthen advanced cancer treatments like immunotherapy.”
Understanding the Mechanism
Chen’s lab has dedicated significant time to exploring how different nutrients influence immune function, and this research builds on that foundation. By examining a broad array of nutrients, they identified zeaxanthin as a key compound that boosts the activity of CD8+ T cells—those immune cells that attack tumor cells. It turns out these T cells rely on a structure called the T-cell receptor (TCR) to find and destroy abnormal cells.
The findings revealed that zeaxanthin stabilizes and enhances the TCR complex on CD8+ T cells when these cells interact with cancer cells. This reinforcement amplifies the internal signaling processes, leading to heightened T-cell activation, increased production of cytokines, and improved tumor-destructive capabilities.
Impact on Immunotherapy
In experiments with mice, dietary zeaxanthin supplementation showed promise by slowing tumor growth. Even more impressively, when combined with immune checkpoint inhibitors—a common form of cancer immunotherapy—zeaxanthin significantly improved anti-tumor responses compared to immunotherapy alone.
Further testing involved human T cells modified to identify specific tumor markers, and zeaxanthin treatment enhanced their effectiveness against melanoma, multiple myeloma, and glioblastoma cells in lab settings.
“Our results indicate that zeaxanthin boosts both natural and engineered T-cell functions, suggesting significant potential for patients undergoing immunotherapies,” Chen noted.
A Safe Supplement
Zeaxanthin is readily available as an over-the-counter supplement intended for eye health and can also be found in various vegetables like orange peppers, spinach, and kale. It’s generally affordable, widely accessible, well-tolerated, and its safety is well-documented, making it a viable option for research as a complement to cancer treatments.
The study underscores the value of a diverse diet. Previous work by Chen’s team highlighted that another dietary fatty acid, trans-vaccenic acid (TVA), also enhances T-cell function but through a different mechanism. Together, these insights emphasize how nutrients from both plant and animal sources could benefit immune health.
Looking Ahead
While the initial results are encouraging, researchers caution that the study remains in an early phase. Most observations are based on lab experiments and animal studies, meaning clinical trials are necessary to assess whether zeaxanthin can truly improve cancer patient outcomes.
“Our research paves the way for a new area within nutritional immunology, focusing on how specific nutrients interact with the immune system at a molecular level,” Chen explained. “With more investigation, we may uncover natural compounds that enhance the effectiveness and accessibility of current cancer therapies.”
